TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK)
CUSIP: 874060205
Q1 2014 13F Holders as of 31 Mar 2014
- Type / Class
- Equity / SPONSORED ADS
- Total 13F shares
- 726,088
- Share change
- -72,658
- Total reported value
- $17,232,000
- Price per share
- $23.75
- Number of holders
- 9
- Value change
- -$1,435,931
- Number of buys
- 4
- Number of sells
- 6
Quarterly Holders Quick Answers
What is CUSIP 874060205?
CUSIP 874060205 identifies TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 874060205:
Top shareholders of TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
—
class O/S missing
|
240,863
|
$5,545,000 | — | 31 Dec 2013 | |
| World Asset Management Inc |
13F
|
Company |
—
class O/S missing
|
99,073
|
$2,274,000 | — | 31 Dec 2013 | |
| Curi Capital, LLC |
13F
|
Company |
—
class O/S missing
|
73,384
|
$1,685,000 | — | 31 Dec 2013 | |
| MARTINGALE ASSET MANAGEMENT L P |
13F
|
Company |
—
class O/S missing
|
69,205
|
$1,589,000 | — | 31 Dec 2013 | |
| ZEVIN ASSET MANAGEMENT LLC |
13F
|
Company |
—
class O/S missing
|
13,801
|
$318,000 | — | 31 Dec 2013 | |
| Calvert Investment Management, Inc. |
13F
|
Company |
—
class O/S missing
|
9,293
|
$214,000 | — | 31 Dec 2013 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
—
class O/S missing
|
8,788
|
$202,000 | — | 31 Dec 2013 | |
| Hexavest Inc. |
13F
|
Company |
—
class O/S missing
|
1,134
|
$26,000 | — | 31 Dec 2013 | |
| LS Investment Advisors, LLC |
13F
|
Company |
—
class O/S missing
|
770
|
$18,000 | — | 31 Dec 2013 | |
| GLENMEDE TRUST CO NA |
13F
|
Company |
—
class O/S missing
|
326
|
$7,000 | — | 31 Dec 2013 | |
| PRIVATE TRUST CO NA |
13F
|
Company |
—
class O/S missing
|
227
|
$5,000 | — | 31 Dec 2013 | |
| FineMark National Bank & Trust |
13F
|
Company |
—
class O/S missing
|
63
|
$1,000 | — | 31 Dec 2013 |
Institutional Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q1 2014
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2014 vs Q4 2013 Across Filers
| Investor | Q4 2013 Shares | Q1 2014 Shares | Share Diff | Share Chg % | Q4 2013 Value $ | Q1 2014 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.